- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
January 3rd, 2006
A new report warns that as nanotechnology becomes a reality, Europe must not miss the boat, and raises the alarm that the potential benefits of nanomedicine in Europe will be lost without major investment in R&D.
The report, the result of a two-year-long study conducted by the European Science Foundation (ESF), concludes that emerging nanomedicine technologies will increasingly serve as new medical tools for diagnostics and therapeutics in various areas of healthcare including drug discovery and development, drug delivery and providing targeted therapy.
|Related News Press|
Crystalline Fault Lines Provide Pathway for Solar Cell Current: New tomographic AFM imaging technique reveals that microstructural defects, generally thought to be detrimental, actually improve conductivity in cadmium telluride solar cells September 26th, 2016
Chains of nanogold – forged with atomic precision September 23rd, 2016
Nanotech Grants Options September 22nd, 2016
Arrowhead Pharmaceuticals to Present at Upcoming September Conferences September 1st, 2016
Industrial Nanotech, Inc. Provides Shareholder Update August 22nd, 2016
Fighting cancer with sticky nanoparticles September 27th, 2016